Sysmex Inostics Competitors and Similar CompaniesClear all

Sysmex Inostics's competitors and similar companies include Interpace Diagnostics, Pyxant Labs, Prometheus Biosciences and MorphoSys.
Sysmex Inostics
Sysmex Inostics
Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
Interpace Diagnostics
Interpace Diagnostics
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
Pyxant Labs
Pyxant Labs
Pyxant Labs is a company operating as a bioanalytical laboratory.
Prometheus Biosciences
Prometheus Biosciences
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
MorphoSys
MorphoSys
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
Founding Date
Founding Date
2008
Founding Date
1987
Founding Date
2000
Founding Date
1995
Founding Date
1992
Type
Type
Subsidiary
Type
Public
Type
Private
Type
Subsidiary
Type
Subsidiary
Tags
Locations
Locations
Hamburg, DE HQ
Kobe, JP
Baltimore, US
Locations
Parsippany-Troy Hills, US HQ
Morrisville, US
Pittsburgh, US
Locations
Colorado Springs, US HQ
Millcreek, US
Locations
San Diego, US HQ
Locations
Planegg, DE HQ
Boston, US
Employees
Employees
65
Employees
8919% increase
Employees
1221% decrease
Employees
9735% increase
Employees
464

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$38.7m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$6.8m (FY, 2022)
Revenue (est.)
€238.3m (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
$14.6m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€34.6m (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
$24.1m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Gross profit
€205.5m (FY, 2023)
Net income
Net income
N/A
Net income
$24.6m (FY, 2025)
Net income
N/A
Net income
($141.8m) (FY, 2022)
Net income
(€189.7m) (FY, 2023)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
1 (FY, 2016)
Patents (US)
N/A
Patents (US)
11 (Mar, 2021)
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 530k
Total funding raised
$ 130m
Total funding raised
$ 126m
For sources of this data, please see the company profile

View Company Profiles

Interpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
89↑ 19% increase

Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.

View company
Pyxant Labs
HQ
Colorado Springs, US
Employees
122↓ 1% decrease

Pyxant Labs is a company operating as a bioanalytical laboratory.

View company
Prometheus Biosciences
HQ
San Diego, US

Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.

View company
MorphoSys
HQ
Planegg, DE

MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.

View company